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Purpose: Werner syndrome is an autosomal recessive disease of premature aging caused by a polymorphic C1367T
mutation in the Werner (WRN) gene. Although there are differences between the pathobiology of normal aging and the
phenotype of Werner syndrome, the clinical age-related changes are similar. The aim of the study was to investigate the
incidence of the C1367T (rs1346044) polymorphism in patients with age-related cataract.
Methods: The study group consisted of 81 patients with senile cataract undergoing cataract extraction surgery. Data on
age, sex, and medical history of microvascular disease and cancer were obtained from the medical files. Anterior lens
capsule material was collected during surgery. DNA was extracted, amplified by polymerase chain reaction, and screened
for the C1367T polymorphism in WRN using restriction enzymes followed by sequencing.
Results: There were 33 male and 48 female patients of mean age 74.3±9 years. Genotypic frequencies were 67% for TT
and 33% for TC. None of the patients had the CC genotype. Ten patients had a history of myocardial infarct, 8
cerebrovascular accident, and 8 various tumors. The distribution of these morbidities was similar in the two genotype
groups.
Conclusions: The distribution of the C1367T WRN polymorphism in patients with senile cataract is similar to that in the
normal population. Cataract formation in the elderly is not linked to a WRN mutation.
Progeria is a rare group of diseases with striking features
that resemble accelerated aging [1].
Werner syndrome is a less well known but more common
form of progeria, with a frequency of 1×105-1×107 depending
on the geographic area [2]. Also termed progeria of adults,
Werner syndrome first becomes apparent in puberty (mean
age) with growth arrest and thinning and graying of the hair.
Other  manifestations  include  skin  wrinkling,  cataract,
osteoporosis, and premature arteriosclerotic disease that leads
to heart attacks and strokes [3-5]. Werner syndrome has also
been  associated  with  various  types  of  cancer  [6].  Many
laboratory  abnormalities  have  been  reported  [7].  The
syndrome is caused by a polymorphic C1367T mutation in the
Werner gene (WRN) located on the short arm of chromosome
8.
WRN encodes a multifunctional nuclear protein of the
RecQ  family  which  functions  as  an  exonuclease  and
endohelicase  [8-12]  with  apparent  involvement  in
transcriptional  and  chromosomal  segregation  and  DNA
repair/recombination [13]. Mutations in WRN lead to a loss of
function of the protein and a breakdown in genome integrity
[14].  Although  the  genetic  basis  of  Werner  syndrome  is
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unknown, the inheritance pattern and paternal age effect, in
addition to the absence of findings of consanguinity, point to
a sporadic dominant mutation.
Diseases  of  premature  aging  have  prompted  interest
among  geneticists  because  the  study  of  their  underlying
mechanisms can provide insights not only into these rare
disorders themselves but also into the normal aging process
[1,15]. While the phenotype of Werner syndrome differs from
the pathobiology of normal aging, the clinical age-related
changes are similar. To date, researchers have investigated the
possible  relationship  of  many  mutations,  deletions,  and
polymorphisms of the WRN gene to such age-related diseases
as cardiovascular disease [6], hypertension, diabetes mellitus,
dementia, osteoporosis [3], and some cancers [16-19]. In the
eye, the literature has focused on complications after cataract
surgery [20,21]; one case of a dislocated lens to the vitreous
has been reported as well [22]. Although bilateral cataract
develops early in patients with Werner syndrome [7], and
other laminopathies have been linked with congenital cataract
[23-26], to our knowledge there are no studies of possible
protein changes in the lens as a result of progeroid mutations
or a link between senile cataract and abnormalities in WRN.
The aim of the present study was to investigate a possible
role of the C1367T (rs1346044) polymorphism in the WRN
gene in age-related cataract in an Israeli population.
METHODS
Patients: The study group included 81 patients undergoing
routine cataract surgery at a major tertiary center. The study
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1771was approved by the institutional and national review boards,
and all patients signed an informed consent form.
All patients were examined preoperatively by slit-lamp,
and cataract type and grade were categorized. Background
data were derived from the medical files. Anterior lens capsule
material excised during surgery (one sample per patient) was
analyzed for the C1367T polymorphism in the WRN gene.
DNA  Isolation:  The  capsules  containing  single-layer  lens
epithelial  cells  were  suspended  in  5  ml  of  conservation
medium until isolation of genomic DNA. DNA was extracted
using  standard  sodium  dodecylsulfate  (SDS)/proteinase  K
digestion  followed  by  phenol-chloroform  extraction  and
ethanol precipitation.
C1367T polymorphism in the WRN gene: A DNA sequence
of 195 bp, which contains the polymorphic site, was amplified
by  polymerase  chain  reaction  (PCR)  using  the  following
primers: 5′-GCC TAA TCA GAA TGT TAG TT-3′ and 5′-
CCT CAG TAT TGA TGC CTA CTT C-3′. Amplification
was performed in a 50-µl reaction volume containing 100 ng
of sample DNA as a template. The PCR parameters were as
follows: denaturation at 95 °C for 3 min, 35 cycles of 45 s at
95 °C, annealing at 58 °C for 45 s, and extension of 1 min at
72 °C with Taq polymerase. The PCR product was amplified
on 2% agarose gel and visualized with ethidium bromide
staining.
Direct sequencing of the PCR products was performed
for  selected  samples,  with  Big  Dye  Terminator  Cycle
Sequencing  reagents  using  the  ABI  PRISM  3700  DNA
Analyzer (Applied Biosystems, Foster City, CA; Figure 1).
The T→C alteration in WRN results in the loss of a BsaA1
restriction site in the abnormal sequence. Therefore, upon
digestion  with  BsaA1  (R0531;  New  England  Biolabs,
Beverly, MA), the normal sequence yielded two fragments of
158 bp and 37 bp, whereas the C-altered sequence yielded
three fragments of 93 bp, 65 bp, and 37 bp, which were
separated on a 4% agarose gel (Figure 2).
Statistical analysis: The results were statistically analyzed
with SPSS for Windows, version 15.0.1 (SPSS- Inc, Chicago,
IL): A p value of less than 0.05 was considered statistically
significant.
Between-group differences in cataract type and grade
were analyzed by the χ2 test; in sex and underlying diseases,
by Fisher exact test; in age, by t-test. Correlations between
variables were analyzed by Pearson correlation test.
RESULTS
Eighty-one patients participated in the study, 33 male (41%)
and 48 female (59%), of mean (±SD) age 74.3±9.6 years
(range:  52–93  years).  Other  morbidities  included
hypertension 66.7%, diabetes mellitus 36.1%, dyslipidemia
48.6%, s/p myocardial infarction 14.1%, s/p cerebrovascular
accident  11.3%,  and  cancer  11.3%  (colorectal  carcinoma,
2.4%, including one patient also with prostate carcinoma;
breast cancer, 2.4%, including one patient also with uterine
carcinoma; transitional cell carcinoma of the bladder, 1.2%;
synovial sarcoma, 1.2%).
Analysis of allele frequencies of the WRN polymorphism
revealed the CT genotype in 33.3% of patients, and the TT
genotype, in 66.67%. No homozygosity for CC was found.
There was no association of genotype polymorphism with the
presence or stage of cataract. The distribution of cataract and
other morbidities by genotype is shown in Table 1.
DISCUSSION
The  present  study  investigated  the  C1367T  WRN
polymorphism and genotype frequencies in elderly patients
with senile cataract. We found that the genotype distribution
was  similar  to  that  reported  in  the  general  population
[26-29], namely 2/3 TT and 1/3 CT. No association was found
between the genotype and type or stage of cataract or other
age-related morbidities.
Molecular studies strongly suggest that aging is triggered
by two mechanisms: DNA damage and telomere shortening
Figure 1. DNA sequencing. CT, TT, and CC polymorphism is demonstrated, respectively. The later is for demonstration, not from the study
population.
Molecular Vision 2010; 16:1771-1775 <http://www.molvis.org/molvis/v16/a192> © 2010 Molecular Vision
1772Figure  2.  The  C1367T  polymorphism.  Following  the  use  of
restriction enzymes, the gel shows: 1, DNA ladder; 2, PCR product
well,  demonstrating  a  195  bp  length  sequence;  3,  TT  well,
demonstrating two lengths of DNA of 158 bp and 37 bp; 4, CT well,
demonstrating 4 DNA lengths of 158 bp, 93 bp, 65 bp, and 37 bp; 5,
CC well, demonstrating 3 DNA lengths of 93 bp, 65 bp, and 37 bp
(example taken as control).
[30]. In the first, the cumulative DNA damage accompanied
by DNA repair deficiencies results in genomic instability and
accelerated  cellular  senescence.  Aging  due  to  both
mechanisms is strongly dependent on the TP53 (p53) status.
The  WRN  gene  is  considered  the  “caretaker”  of  the
genome [31], with the protein serving as an important link
between repair of defective DNA and processes related to
aging.  The  gene  is  expressed  within  the  central  nervous
system  and  throughout  the  brain,  and  is  present  in  both
neurons and glia. Analysis of WRN RNA levels throughout
the life cycle revealed the highest levels in embryonic brain
tissue and a biphasic pattern of expression from the early
postnatal  period  into  adulthood.  Mutations  in  WRN  are
believed to result in the deleterious loss of normal WRN
function.
The  eye  is  part  of  the  central  nervous  system.  The
transparency  of  the  lens  is  maintained  by  a  specific
mechanism of nuclear differentiation and elimination of the
lens fiber cells followed by apoptosis [10]. The purpose of the
lens denucleation is to reduce light scatter. Studies of normal
aging  of  the  lens  suggest  that  transcriptional  shutdown
precedes laminar reorganization and chromatin breakdown
during lens fiber cell denucleation [15].
Senile cataract, which disrupts normal lens denucleation,
is one of the most common age-related disorders. It manifests
early  in  most  patients  with  Werner  syndrome,  a  classic
progeroid premature-aging syndrome caused by a single-gene
mutation. Although the function of WRN has been intensively
investigated in primary fibroblast and fibroblast cell lines,
little is known about the normal expression pattern of the
protein in the eye. We speculated that a search for the C1367T
WRN  polymorphism  responsible  for  Werner  syndrome  in
elderly  patients  with  cataract  might  shed  light  on  the
TABLE 1. WRN ALLELE POLYMORPHISM, CATARACT GRADING AND SYSTEMIC CO-MORBIDITIES.
  Gene polymorphism  
Disorder C/T n=27 (33%) T/T n=54 (66.7%) Statistical
significance
Nuclear cataract
Stage 0 1 4 NS
Stage 1 9 28 NS
Stage 2 14 24 NS
Stage 3 8 9 NS
Stage 4 3 3 NS
Hypertension 70 65 NS
Diabetes mellitus type 1 39 35 NS
Dyslipidemia 38 54 NS
Myocardial infarct 16 13 NS
Cerebro-vascular accident 4 7 NS
Tumor 12 11 NS
          In the Table, “NS” indicates not statistically significant.
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process of the eye [32]. However, we did not identify any
homozygosity of the CC alleles, and the distribution of the
heterozygous polymorphism was similar to that found in the
general Israeli population (~33%). Cataract, and other age-
related diseases, were not linked to a mutation of the WRN
gene.
These results are in line with the larger Elderly Brazilian
Longitudinal Study [26], wherein no association was found
between WRN C1367T and cardiovascular diseases, diabetes
mellitus type 2, obesity, dementia, depression, and neoplasms.
In addition, Bohr et al. [27], in the Baltimore Longitudinal
Study of Aging, failed to show any influence of the WRN
polymorphism on coronary artery disease. However, studies
in Japanese populations found that patients homozygous for
TT were at nearly threefold higher risk of myocardial infarct
than  the  general  population  [33];  other  researchers  from
countries other than Japan reported a similar risk for CT in
their populations [34]. CC homozygosity posed a lower risk
[34,35] and also protected against the development of type 2
diabetes mellitus [36]. In the present study, in which none of
the patients had the CC genotype, the distribution of type 2
diabetes was similar in patients with TT and TC.
Studies of central nervous system diseases in this context
yielded  no  association  of  the  WRN  polymorphism  with
increased risk of either Alzheimer disease [28] or gliomas
[29]. Breast cancer was not associated with C1367T, but it
was associated with another polymorphism of the WRN gene,
A46729C [37].
The  lack  of  an  association  of  the  WRN  C1367T
polymorphism and senile cataract in the present study could
suggest that abnormalities in WRN in position C1367T do not
lead to abnormal lens fiber cell denucleation in adults or that
the influence of the protein on lens laminopathies is not crucial
to the lens aging process. The lack of association with other
age-related  morbidities  might  distinguish  Israelis  from
Japanese and other populations, or it might be explained by
the limited number of participants in our sample. Additional
studies are needed to further investigate possible links of
WRN  polymorphisms  with  age-related  diseases,  including
cataract.
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